The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy

Čájet eará veršuvnnaid (1)

Renin-angiotensin-aldosterone system inhibitors prevent the progression of kidney disease in patients with diabetic nephropathy, and we studied how that benefit varies by the type of diabetes and baseline urinary albumin. We pooled data from 49 randomized controlled trials in a meta-analysis using t...

Bibliográfalaš dieđut
Váldodahkkit:	Taylor, K, Stevens, R, Blacklock, C, Roberts, N, Pugh, C, Farmer, A, Hirst, J
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2012

Geahča maid

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy.
Dahkki: Hirst, J, et al.
Almmustuhtton: (2012)

Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysis.
Dahkki: Blacklock, C, et al.
Almmustuhtton: (2011)

Analysis of renin-angiotensin aldosterone system gene polymorphisms in Malaysian essential hypertensive and type 2 diabetic subjects
Dahkki: Ramachandran, Vasudevan, et al.
Almmustuhtton: (2009)

Renin-Angiotensin System Gene Variants and Type 2 Diabetes Mellitus: Influence of Angiotensinogen
Dahkki: Joyce-Tan, S.M., et al.
Almmustuhtton: (2016)

Gene polymorphisms of angiotensin-converting enzyme, angiotensin type 1 receptor and ⁪⁯α-adducin associated with renin angiotensin-aldosterone system in Malaysian end-stage renal disease patients
Dahkki: Ali, Aisyah
Almmustuhtton: (2012)

Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin-dependent diabetes mellitus.
Dahkki: Chowdhury, T, et al.
Almmustuhtton: (1997)

The Interaction Of Renin-Angiotensin And Sympathetic Nervous Systems In Diabetes And Hypertension
Dahkki: Lazhari, Mohamed Ibrahim A. Ali
Almmustuhtton: (2004)

Erratum: The role of genetic polymorphisms within the renin-angiotensin system in susceptibility to diabetic nephropathy in IDDM subjects (Journal of the British Diabetic Association (1996) 13 (92))
Dahkki: Chowdhury, T, et al.
Almmustuhtton: (1996)

Monitoring young people with type 1 diabetes for diabetic nephropathy: potential errors of annual ACR testing.
Dahkki: Oke, J, et al.
Almmustuhtton: (2013)

Monitoring young people with type 1 diabetes for diabetic nephropathy: Potential errors of annual ACR testing
Dahkki: Oke, J, et al.
Almmustuhtton: (2013)

Longitudinal estimated GFR trajectories in patients with and without type 2 diabetes and nephropathy
Dahkki: Weldegiorgis, M, et al.
Almmustuhtton: (2017)

The role of genetic polymorphisms within the renin-angiotensin system in susceptibility to diabetic nephropathy in IDDM subjects (vol 13, pg 92 1996)
Dahkki: Chowdhury, T, et al.
Almmustuhtton: (1996)

Familial and phenotypic associations of the aldosterone Renin ratio.
Dahkki: Alvarez-Madrazo, S, et al.
Almmustuhtton: (2009)

The analysis and reporting of cardiovascular and neoplastic event data in type 2 diabetic populations with diabetic nephropathy: a systematic review
Dahkki: Feakins, B, et al.
Almmustuhtton: (2014)

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
Dahkki: Coleman, R, et al.
Almmustuhtton: (2005)

Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM.
Dahkki: Chowdhury, T, et al.
Almmustuhtton: (1996)

SASARAN AKSI VITAMIN D PADA SISTEM RENIN ANGIOTENSIN-ALDOSTERON DALAM PENGATURAN TEKANAN DARAH SISTOLIK
Dahkki: , Dessy Hermawan, Ns., M.Kes, et al.
Almmustuhtton: (2013)

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
Dahkki: Adler, A, et al.
Almmustuhtton: (2003)

The canosinase gene (CNDP1) is not a protection factor of diabetic nephropathy in type 1 diabetics
Dahkki: Vionnet, N, et al.
Almmustuhtton: (2006)

Ethnic differences in diabetic nephropathy - The UKPDS
Dahkki: Stevens, R, et al.
Almmustuhtton: (1999)

Prevalence of high aldosterone-renin ratio and plasma aldosterone levels among hypertensive patients at a primary care clinic
Dahkki: Omar , Ahmad Marzuki, et al.
Almmustuhtton: (2013)

A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes
Dahkki: Taira, M, et al.
Almmustuhtton: (2018)

U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM.
Dahkki: Dudley, C, et al.
Almmustuhtton: (1995)

Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type 1 diabetes.
Dahkki: Schultz, C, et al.
Almmustuhtton: (2000)

Development of an enzyme immunoassay for angiotensin I and renin
Dahkki: , SASMITO, Ediati, et al.
Almmustuhtton: (1985)

Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study
Dahkki: Sato, K, et al.
Almmustuhtton: (2022)

Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review.
Dahkki: Sjølie, A, et al.
Almmustuhtton: (2011)

Diabetic nephropathy : east meets west.
Dahkki: Chew, Siew Tiang.
Almmustuhtton: (2010)

Analysis of genetic polymorphism as risk factor of diabetes nephropathy among type 2 diabetic patients of a tertiary hospital
Dahkki: Yahya, Mohd Jokha
Almmustuhtton: (2017)

Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.
Dahkki: Kunz, R, et al.
Almmustuhtton: (2008)

Diabetes in pregnancy: time to focus on women with type 2 diabetes
Dahkki: Hirst, JE, et al.
Almmustuhtton: (2021)

KAJIAN EFEKTIVITAS MONOTERAPI ANTIHIPERTENSI PENGHAMBAT RENIN ANGIOTENSIN PADA PENYANDANG DIABETES MELLITUS TIPE 2 DENGAN HIPERTENSI
Dahkki: , Mesi Leorita, et al.
Almmustuhtton: (2014)

LEUKOCYTE PH AND NA+/H+ ANTIPORT ACTIVITY IN TYPE-1 (INSULIN-DEPENDENT) DIABETES WITH NEPHROPATHY
Dahkki: Ng, L, et al.
Almmustuhtton: (1989)

Leucocyte Na+/H+ antiport activity in type 1 (insulin-dependent) diabetic patients with nephropathy.
Dahkki: Ng, L, et al.
Almmustuhtton: (1990)

Risk factors for the development and progression of diabetic nephropathy
Dahkki: Hussin, Ahmad Munawwir
Almmustuhtton: (2002)

Quantification of beta-defensins (DEFB) gene copy number variations in relation to inflammation in type 2 diabetes mellitus and diabetic nephropathy patients
Dahkki: Yusoff, Maryam Jamielah, et al.
Almmustuhtton: (2020)

CNDP1, NOS3, and MnSOD polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients in Malaysia
Dahkki: Yahya, Mohd Jokha, et al.
Almmustuhtton: (2019)

The Interaction Of Renin-angiotensin And Sympathetic Systems In Hypertension And Heart Failure
Dahkki: Am Astita, Rehab
Almmustuhtton: (2004)

Prevalence and progression of diabetic nephropathy in South Asian, white European and African Caribbean people with type 2 diabetes: a systematic review and meta-analysis
Dahkki: Jadawji, C, et al.
Almmustuhtton: (2018)

ACE inhibitors and statins in adolescents with type 1 diabetes
Dahkki: Marcovecchio, M, et al.
Almmustuhtton: (2017)